share_log

再鼎医药(09688.HK)完成发售美国存托股份及悉数行使期权

Zai Lab (09688.HK) has completed the offering of American depositary shares and the full exercise of options.

Gelonghui Finance ·  Nov 22, 2024 23:03

Gelonghui, November 22, 丨 Zaiding Pharmaceutical (09688.HK) announced that on November 18, 2024 (US Eastern Time), it completed the sale of a total of 7,843,137 underwritten American Depositary Shares to the public at US$25.50 per American Depositary Share (equivalent to approximately HK$19.84 per related share (based on the ratio of each 10 shares to 1 American Depositary Share)).

Furthermore, underwriters have exercised all of their options to purchase an additional 1,176,470 American Depositary Shares at the offer price less underwriting discounts and commissions. Further settlement of American Depositary Shares relating to options was completed on November 19, 2024 (EST).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment